Almokalant
Appearance
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H28N2O3S |
Molar mass | 352.5 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Almokalant is drug used to treat arrhythmia.[1] It is a potassium channel blocker. It has been found to have teratogenic effects in rats.[2]
References
- ^ Wiesfeld A C; Crijns H J; Bergstrand R H; Almgren O; Hillege H L; Lie K I (1993). "Torsades de pointes with Almokalant, a new class III antiarrhythmic drug". American heart journal. 126 (4): 1008–1011. doi:10.1016/0002-8703(93)90726-p.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Wellfelt, K.; Sköld, A. C.; Wallin, A.; Danielsson, B. R. (1999-04-01). "Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species". Reproductive Toxicology (Elmsford, N.Y.). 13 (2): 93–101. ISSN 0890-6238. PMID 10213516.